Boyer-Diaz Z, Aristu-Zabalza P, Andres-Rozas M, Robert C, et al. Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease. J Hepatol 2020 Dec 2. pii: S0168-8278(20)33832.
PMID: 33278455